Delivery Order SPE2DB22D2206-SPE2DB24FGG16
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MEKINIST 0.05 MG/ML SOLUTION 90ML, a medication, with an ultimate completion date of July 16, 2025 and a ceiling value of $4,460.92. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MEKINIST 2 MG TABLET UU 30S, a pharmaceutical product, with a potential value of $8,878.79. The order has a completion date of March 18, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2025,...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract is for the delivery of MEKINIST 2 MG TABLET pharmaceutical products, with a ceiling value of $17,018.12 and a period of performance through April 22, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MEKINIST 2 MG TABLET UU 30S, a prescription medication. The award, valued at $17,757.60, has an ultimate completion date of August 28, 2024. It is a firm-fixed-price contract and does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of the pharmaceutical product MEKINIST 2 MG TABLET UU 30S, with a ceiling value of $19,341.02 and a performance period through June 2, 2025. The contract is designated as a Firm Fixed Price Delivery Order, without any set-aside requirements. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $6,064.14 firm fixed price order is for the supply of Mekinist 0.05 mg/ml solution, a prescription medication. This order is part of a larger, indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, which has a potential value of...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,714.72 fixed-price delivery order is for the supply of MEKINIST 0.5 MG TABLET medical products, with a period of performance through July 31, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,341.02 firm fixed-price delivery order is for the supply of 4,568,131,488 units of the medication MEKINIST 2MG TAB 30S. The contract has an ultimate completion date of May 27, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award, with ID SPE2DB22D3004|SPE2DB25FPK75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $9,670.51 firm fixed-price delivery order is for the supply of MEKINIST 2 MG TABLET medication. The contract has an ultimate completion date of February 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides for the delivery of MEKINIST 2 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $8,878.79 firm fixed price delivery order was issued under an indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGG16Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MEKINIST 0.05 MG/ML SOLUTION 90ML, a pharmaceutical product. The award has a ceiling value of $4,042.76 and a performance period through April 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order has no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 3/23/24 |